Attached files
file | filename |
---|---|
8-K - FORM 8-K - Medite Cancer Diagnostics, Inc. | mdit8k_jan112017.htm |
Exhibit 16.1
January
11, 2017
Securities and
Exchange Commission 100 F Street, N.E.
Washington, D.C.
20549 Ladies and Gentlemen:
We were
previously principal accountants for Medite Cancer Diagnostics,
Inc. (the Company) and on April 12, 2016, we reported on the
consolidated financial statements of the Company as of and for the
year ended December 31, 2015. On January 5, 2017, we were dismissed
as the Company’s independent registered public accounting
firm.
We have
read the Company’s statements included under Item 4.01 of its
Form 8-K dated January 11, 2017, and we agree with such statements,
except that we are not in a position to agree or disagree with (i)
the Company’s statement that the audit committee of the board
of directors engaged KMJ Corbin & Company LLP (KMJ) as the
Company’s independent registered public accounting firm, (ii)
the Company’s statement that KMJ was not consulted regarding
the application of accounting principles to a specified
transaction, either completed or proposed, or the type of audit
opinion that might be rendered on the Company’s financial
statements and (iii) the Company’s statement that KMJ did not
provide any written reports or oral advice considered by the
Company in reaching a decision as to the accounting, auditing or
financial reporting or any of the matters or events set forth in
Item 304 of Regulation S-K.
Very
truly yours,
/s/
WithumSmith+Brown, PC
Orlando, Florida